skip to content
Primary navigation

Revatio Adcirca

Drug - Adcirca (tadalafil) [United Therapeutics], Revatio (sildenafil) [Pfizer]

December 2009

Therapeutic area - Pulmonary Arterial Hypertension


Revatio or Adcirca is approved for use for pulmonary arterial hypertension.

Only one drug will be approved per patient.

Adcirca is subject to prescribing limits of two per day.


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top